Life Sciences & Health

Life Sciences & Healthcare

Our dynamic and progressive Life Sciences team is nimble, creative and innovative in their approach to pushing the boundaries of science and law and bringing you closer to your aspirations and goals.

Jump straight to:

Cross-border Patent Litigation Team of the Year

Managing IP Awards 2025

Impact Case of the Year

LMG Life Sciences Awards 2026

Tier 1 Life Sciences and Healthcare

Legal 500 2026

Our team offers clients a full-service approach, with transactional, tax, competition, intellectual property, medicines regulatory and compliance professionals working seamlessly together to support Life Sciences companies who push the boundaries of science and law.

 

Please select

Out-Law / Your daily need to know in Life Sciences & Healthcare

Our latest work

Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.

  • Latch Medical Limited

    Advised Latch Medical Limited, a healthcare technology business, on an equity fundraising.

  • Client confidential

    Advised a major listed healthcare and pharmaceutical distribution business on complex multi-party litigation in the Queensland Supreme Court and Federal Circuit and Family Court. Matters involved third-party claims arising from former employee conduct and enterprise agreement disputes, addressing employer indemnification, workforce restructures, and national industrial relations strategy issues.

  • Horizon 3 Healthcare Pty Ltd

    Advised Horizon 3 Healthcare, a healthcare investment fund as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.

    Read more
  • Client confidential

    Advising Irish healthcare company on Trade Mark registration and brand protection.

  • Client confidential

    Acting in Commercial Court proceedings for Life Sciences company in relation to licence and supply agreement dispute.

  • Client confidential

    Acting for Pharmaceutical company in relation to enforcement of its patent rights in Ireland.

  • Client confidential

    Advising a US technology group, including representation in negotiations with the works council on the conclusion of IT works agreements.

  • Cairnwell Developments Limited

    Advising Cairnwell Developments Limited, a property development company operating in the healthcare sector in connection with claims by a building contractor for additional compensation. We advised in relation to a series of adjudications (including a smash and grab adjudication) concerning payment, time and defects.

  • Client confidential

    Advising a healthcare wholesaler on its strategic supplier arrangements with key customers in Australia, including structuring security of payment arrangements, equity options over the strategic supplier’s business and associated protections.

  • Advanz Pharma GmbH

    Advised a major international Private Equity-backed intellectual property advisory business on its expansion in the German market.

Our expertise, at your disposal

With over 490 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.

Latest press releases

Show me all press releases

Pinsent Masons wins at FT Innovative Lawyers Europe 2026

Multinational law firm Pinsent Masons has been named the eighth most innovative European law firm at this year’s FT Innovative Lawyers Europe Awards. The firm also won in the Innovative Lawyers in Sustainability category.

Pinsent Masons advises SERT on transformational internalisation

Multinational law firm Pinsent Masons has advised Stoneweg Europe Stapled Trust (SERT) on its proposed aggregate c.€122 million acquisition of Stoneweg's pan-European investment management platform, a transformational transaction that will establish SERT as a fully integrated real estate owner, operator and investment manager with approximately €3.2 billion of assets under management.

Pinsent Masons advises Ghelamco on a €285m transaction in the Polish office market

Multinational law firm Pinsent Masons has advised developer Ghelamco on the €285 million sale of The Bridge, a landmark Warsaw office tower. 

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.